Inventor · disambiguated record
Christophe Caux
Also filed as: CAUX CHRISTOPHE
14 granted patents·13 pending applications·161 citations·filing 1996–2020
92Inventor score
Top patents by PatentIndex Score
27 records- 0193US9376493B2Antibodies directed against ICOS and uses thereofFAGET JULIEN·Filed 2012·Granted Jun 28, 2016·48 cites·4 claims
- 0290US9676852B2Antibodies directed against ICOS and uses thereofINSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE)·Filed 2016·Granted Jun 13, 2017·8 cites·17 claims
- 0389US11180556B2Antibodies directed against ICOS and uses thereofINST NAT SANTE RECH MED·Filed 2018·Granted Nov 23, 2021·2 cites·8 claims
- 0489US10745482B2Antibodies directed against ICOS and uses thereofINSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECH MEDICALE)·Filed 2019·Granted Aug 18, 2020·2 cites·7 claims
- 0588US9975950B2Antibodies directed against ICOS and uses thereofINST NAT SANTE RECH MED·Filed 2017·Granted May 22, 2018·5 cites·17 claims
- 0684US10633446B2Antibodies directed against ICOS and uses thereofINST NAT SANTE RECH MED·Filed 2019·Granted Apr 28, 2020·1 cites·20 claims
- 0783US11130817B2CD73 blocking agentsINNATE PHARMA·Filed 2016·Granted Sep 28, 2021·3 cites·5 claims
- 0881US6645491B1Method for treating inflammatory conditions using an antibody to MIP-3αSCHERING CORP·Filed 2000·Granted Nov 11, 2003·14 cites·22 claims
- 0981US6004807AIn vitro generation of human dendritic cellsSCHERING CORP·Filed 1996·Granted Dec 21, 1999·59 cites·6 claims
- 1074US7700728B2Use of chimeric receptors in a screening assay for identifying agonists and antagonists of cell receptorsSCHERING CORP·Filed 2006·Granted Apr 20, 2010·7 cites·9 claims
- 1174US2010086560A1Chemokines as adjuvants of immune responseSCHERING CORP·Filed 2009·Application pending·0 cites
- 1273US7217700B2Chemokines as adjuvants of immune responseSCHERING CORP·Filed 2001·Granted May 15, 2007·3 cites·11 claims
- 1373US2020347134A1Antibodies Directed Against ICOS and Uses ThereofINST NAT SANTE RECH MED·Filed 2020·Application pending·0 cites
- 1468US2007166280A1Chemokines as adjuvants of immune responseSCHERING CORP·Filed 2007·Application pending·0 cites
- 1563US2007128159A1Chemokines as adjuvants of immune responseSCHERING CORP·Filed 2007·Application pending·0 cites
- 1659US2003077247A1Chemokines as adjuvants of immune responseSCHERING CORP·Filed 2002·Application pending·0 cites
- 1756US2003138413A1Methods for treating cancerSCHERING CORP·Filed 2002·Application pending·0 cites
- 1854US2009087440A1Methods for Treating CancerSCHERING CORP·Filed 2008·Application pending·0 cites
- 1954US2004042998A1Chemokine uses; compositions; methodsFiled 2003·Application pending·0 cites
- 2049US2021330774A1Herv-k-derived antigens as shared tumor antigens for anti-cancer vaccineCENTRE LEON BERARD·Filed 2019·Application pending·0 cites
- 2149US2003032094A1Isolated mammalian dendritic cell genes; related reagentsFiled 2001·Application pending·0 cites
- 2241US2003008840A1Methods for treating cancerSCHERING CORP·Filed 2002·Application pending·0 cites
- 2339US6361939B1Isolated mammalian dendritic cell genes; related reagentsSCHERING CORP·Filed 1997·Granted Mar 26, 2002·7 cites·16 claims
- 2438US2020232974A1Lymphocytes expressing cd73 in cancerous patient dictates therapyCENTRE LEON BERARD·Filed 2017·Application pending·0 cites
- 2538US2012309013A1Use of the Combinatorial Diversity of T-Lymphocyte Repertoire as a Prognostic Marker of CancerCAUX CHRISTOPHE·Filed 2010·Application pending·0 cites
- 2635US6271014B1Mammalian proteinases; related reagents and methodsSCHERING PLOUGH CORP·Filed 1998·Granted Aug 7, 2001·2 cites·13 claims
- 2731US6812004B1Mammalian dendritic cell chemokine reagentsSCHERING CORP·Filed 1997·Granted Nov 2, 2004·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Christophe Caux files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →